kabutan

SUSMED,Inc.(4263) Summary

4263
TSE Growth
SUSMED,Inc.
918
JPY
-37
(-3.87%)
Apr 30, 10:13 am JST
5.72
USD
Apr 29, 9:13 pm EDT
Result
PTS
outside of trading hours
917
Apr 30, 10:08 am JST
Summary Chart Historical News Financial Result
PER
PBR
3.79
Yield
ー%
Margin Trading Ratio
4.38
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
943 JPY 5.88 USD
Previous Close Apr 28
955 JPY 5.99 USD
High Apr 30, 9:00 am
943 JPY 5.88 USD
Low Apr 30, 9:21 am
909 JPY 5.67 USD
Volume
64,400
Trading Value
0.06B JPY 0.37M USD
VWAP
921.44 JPY 5.75 USD
Minimum Trading Value
91,800 JPY 572 USD
Market Cap
0.02T JPY 0.10B USD
Number of Trades
169
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
Slightly High
1-Year Average
793
1-Year High Jul 29, 2025
12,387
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 369,800 1,324,800 3.58
Apr 17, 2026 323,000 1,295,000 4.01
Apr 10, 2026 325,700 1,315,100 4.04
Apr 3, 2026 336,100 1,148,500 3.42
Mar 27, 2026 339,000 1,154,900 3.41
Company Profile
SUSMED, Inc. develops therapeutic applications for patients and provides systems to streamline pharmaceutical development. The company collaborates with pharmaceutical firms.
Sector
Information & Communication
SUSMED, Inc. focuses on developing therapeutic applications and providing support systems for pharmaceutical development. Their insomnia treatment application has received medical device approval and is preparing for insurance coverage. The company is currently developing multiple therapeutic applications, including an exercise therapy app for breast cancer patients and an ACP provision app. SUSMED, Inc. has developed and offers a general-purpose clinical trial system to improve the efficiency of clinical trials, as well as an AI platform called "Awesome Intelligence" for medical data analysis. The company is also working on implementing a remote clinical trial system utilizing blockchain technology. Additionally, SUSMED, Inc. provides DTx development support services for pharmaceutical companies and research institutions.